pain d'epi
Selected indexed studies
- Impact of breakthrough pain on community-dwelling cancer patients: results from the National Breakthrough Pain Study. (Postgrad Med, 2017) [PMID:27846789]
- Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experience. (Med Oncol, 2015) [PMID:25636506]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Impact of breakthrough pain on community-dwelling cancer patients: results from the National Breakthrough Pain Study. (2017) pubmed
- Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experience. (2015) pubmed